NR4A1 and breast cancer: Recent meta-analyses of observational studies have revealed that aspirin (acetylsalicylic acid; aspirin) could reduce the risk of breast cancer due to its anti-inflammatory effects, mainly in the hormone receptor-positive breast cancer subtype2,3.